Live tape
Top 8, mentions 7d8,860GOOGL1,692 mentions▲ +0.04MRNA1,354 mentions▲ +0.09SNDK1,285 mentions▲ +0.11META1,126 mentions▲ +0.03NVDA1,045 mentions▲ +0.08SPCX900 mentions▲ +0.08NBIS744 mentions▲ +0.09MSFT714 mentions▲ +0.05

Equity · Consumer Cyclical

SLGN

Silgan Holdings Inc. · NYSE

$47 0.00% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 38 sessions
$50 $35 22 May 17 Jul

The line runs $37.91 on 22 May through $47 on 17 July, on a scale from $35 to $50. Days the market did not trade hold the previous close, flat.

The chart above plots the price of SLGN over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 38 sessions over that window: $37.91 on 22 May 2026 through $47 on 17 July 2026.

Market cap $5.0B
P/E (TTM) 14.6
52-week range $36 – $56.04
Avg volume 245.4K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

SLGN insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 27 May 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 8

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
27 May 2026 ABRAMSON LEIGH J Director Award 3,254
27 May 2026 ALLOTT ANTHONY J Director Award 3,254
27 May 2026 Cleland Nielsen Fiona Director Award 3,254
27 May 2026 DONOVAN WILLIAM T Director Award 3,254
27 May 2026 LEWIS ROBERT B Director Award 3,254
27 May 2026 LICH BRAD A Director Award 3,254
27 May 2026 Miller Shannon Director Award 3,254
27 May 2026 Ramdev Niharika Director Award 3,254

SLGN reported financials

SEC EDGAR XBRL

SLGN reported revenue of $6.5B for the fiscal year ended 31 Dec 2025. Net income over the same period was $288.4M.

Figure Reported Period
Revenue $6.5B 31 Dec 2025 fiscal year
Net income $288.4M 31 Dec 2025 fiscal year
Diluted EPS $2.70 31 Dec 2025 fiscal year
Total assets $9.6B 30 Jun 2026 at period end
Total equity $2.4B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

SLGN earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.72
31 Mar 2026 Q1 2026 $0.60
31 Dec 2025 FY 2025 $2.70
30 Sep 2025 Q3 2025 $1.06
30 Jun 2025 Q2 2025 $0.83
31 Mar 2025 Q1 2025 $0.63
31 Dec 2024 FY 2024 $2.58
30 Sep 2024 Q3 2024 $0.93

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SLGN institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a SLGN position for the quarter ended 30 Jun 2026 — a combined $228.1M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Millennium Management Added +43.0% shares 2,795,957 $129.7M
Two Sigma Investments Added +136.3% shares 666,541 $30.9M
Point72 Asset Management Held (±25%) −23.0% shares 566,868 $26.3M
AQR Capital Management Added +310.7% shares 390,820 $17.9M
Citadel Advisors Added +54.5% shares 317,660 $14.7M
Balyasny Asset Management New position 146,322 $6.8M
Bridgewater Associates New position 17,253 $800K
D. E. Shaw & Co. Trimmed −82.1% shares 12,834 $595K
GAMCO Investors Held (±25%) −3.6% shares 8,035 $373K
Man Group Exited

Source: SEC EDGAR 13F filings

SLGN fails-to-deliver

SEC CNS data

On 31 Jul 2026, 15 shares of SLGN failed to deliver (about $616).

Settlement date Shares failed Notional % of shares out
31 Jul 2026 15 $616 <0.001%
28 Jul 2026 355 $17K <0.001%
24 Jul 2026 544 $25K 0.001%
20 Jul 2026 88 $4K <0.001%
17 Jul 2026 48 $2K <0.001%
14 Jul 2026 1,593 $72K 0.002%
09 Jul 2026 649 $29K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in SLGN

STOCK Act disclosures

The most recent congressional trade disclosed in SLGN is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 15 Jan 2026.

Date Member Type Amount
15 Jan 2026 filed 13 Feb 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures